AlphaTON Capital updates strategic roadmap, net fundraising reaches 44 million USD, plans to transform into a privacy AI infrastructure provider

According to the latest documents disclosed by the U.S. Securities and Exchange Commission (SEC), Amphastar Pharmaceuticals Inc has signed a five-year supply agreement, under which all payments will be settled in RMB.

Columbia Financial, Inc. announced it will issue common stock in connection with the conversion of its subsidiary, Columbia Bank MHC, from a mutual holding company to a stock holding company structure.

Sylvamo has filed documents with the U.S. Securities and Exchange Commission (SEC), announcing that selling shareholders plan a secondary offering of common stock, with the issuance scale up to 6.3 million shares.

Incyte recently announced that its innovative drug Zynyz® (Retifanlimab) has been approved by the European Commission as a first-line treatment for advanced squamous cell anal carcinoma (SCAC).